Imago BioSciences (IMGO)
NASDAQ:IMGO
US Market
Holding IMGO?
Track your performance easily

Imago BioSciences (IMGO) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

IMGO Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Imago
BioSciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IMGO Stock 12 Month Forecast

There Are No Analyst Ratings for IMGO In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IMGO Financial Forecast

No data currently available

IMGO Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

IMGO Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
$36
Hold
Downgraded
11/28/22
Stifel Downgrades Imago BioSciences to Hold, Raises Price Target to $36
Cowen & Co.
$36
Hold
Downgraded
11/21/22
Imago BioSciences downgraded to Market Perform from Outperform at CowenCowen analyst Marc Frahm downgraded Imago BioSciences ( IMGO ) to Market Perform from Outperform with a $36 price target after Merck (MRK) announced it will acquire Imago for $36 per share in cash for an approximate total equity value of $1.35B.
Jefferies
$36
Hold
Downgraded
11/21/22
Imago BioSciences downgraded to Hold from Buy at JefferiesJefferies analyst Maury Raycroft downgraded Imago BioSciences ( IMGO ) to Hold from Buy with a price target of $36, up from $35, after Merck (MRK) announced it will acquire Imago for $36 per share in cash for an approximate total equity value of $1.35B.
Wedbush
$36
Hold
Downgraded
11/21/22
Wedbush Downgrades Imago BioSciences to Neutral, Raises Price Target to $36

IMGO Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IMGO Stock Forecast FAQ

What is IMGO’s average 12-month price target, according to analysts?
Currently, no data Available
What is IMGO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IMGO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IMGO a Buy, Sell or Hold?
      Currently, no data Available
      What is Imago BioSciences’s price target?
      Currently, no data Available
      What do analysts say about Imago BioSciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IMGO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis